Skip to main content

Crinetics Pharmaceuticals, Inc.

CRNXDelisted Sep 1, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001658247

Crinetics Pharmaceuticals, Inc. was delisted on Sep 1, 2026; its insiders filed their last Form 4 on Sep 1, 2026; 267 institutions reported holding it in 13F filings for Q2 2026, worth $4.63B in total; no superinvestor held it.

Superinvestors holding CRNX, Q2 2026

See all superinvestors

No superinvestor reported holding CRNX in Q2 2026.

Moves by quarter

Superinvestors that opened, added to, trimmed or sold out of CRNX each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.

  1. Q1 2025

    0 superinvestors holding at quarter end

    Sold out
    Duquesne Family Office
  2. Q4 2024

    1 superinvestor holding at quarter end

    Reduced
    Duquesne Family Office (−60.3%)
  3. Q1 2024

    1 superinvestor holding at quarter end

    New
    Duquesne Family Office